- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Imation issues warning on second-quarter profit
Imation issues warning on second-quarter profitImation late last month warned the financial community that its second-quarter net income and earnings per share are expected to be below analysts' estimates, due to weaker demand for the Oakdale,
Imation issues warning on second-quarter profit
Imation late last month warned the financial community that its second-quarter net income and earnings per share are expected to be below analysts' estimates, due to weaker demand for the Oakdale, MN, company's data-storage products. Wall Street was expecting the company to post second-quarter earnings in the range of 30 to 38 a share.
Sales of Imation's lower capacity data-storage products, like its Travan minicartridges, have been slower than expected, the company said. The company's broader portfolio of products in the medical imaging, printing and publishing, photo color, and data-center markets continues to meet expectations, however. Imation executives said the company's results should improve as higher capacity data-storage products it is developing hit the market.
In other news, Imation acquired Imaginet of Minneapolis, a privately held provider of Internet services to manufacturing and service companies. Imation has formed Imation Internet Services, a new business unit that will offer Internet and intranet-based services to customers, including those in the medical imaging industry.
Four Strategies to Address the Tipping Point in Radiology
January 17th 2025In order to flip the script on the impact of the radiology workforce shortage, radiology groups and practices need to make sound investments in technologies and leverage partnerships to mitigate gaps in coverage and maximize workflow efficiencies.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.
